CTMX
Price
$2.38
Change
-$0.00 (-0.00%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
374.96M
19 days until earnings call
MLEC
Price
$3.95
Change
+$0.02 (+0.51%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
15.72M
101 days until earnings call
Interact to see
Advertisement

CTMX vs MLEC

Header iconCTMX vs MLEC Comparison
Open Charts CTMX vs MLECBanner chart's image
CytomX Therapeutics
Price$2.38
Change-$0.00 (-0.00%)
Volume$5.67K
Capitalization374.96M
Moolec Science SA
Price$3.95
Change+$0.02 (+0.51%)
Volume$300
Capitalization15.72M
CTMX vs MLEC Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. MLEC commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and MLEC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (CTMX: $2.38 vs. MLEC: $3.93)
Brand notoriety: CTMX and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 29% vs. MLEC: 113%
Market capitalization -- CTMX: $374.96M vs. MLEC: $15.52M
CTMX [@Biotechnology] is valued at $374.96M. MLEC’s [@Biotechnology] market capitalization is $15.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTMX and MLEC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while MLEC’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 2 bearish.
  • MLEC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than MLEC.

Price Growth

CTMX (@Biotechnology) experienced а -8.46% price change this week, while MLEC (@Biotechnology) price change was -31.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CTMX is expected to report earnings on Nov 06, 2025.

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($375M) has a higher market cap than MLEC($15.7M). CTMX YTD gains are higher at: 131.068 vs. MLEC (-50.875). CTMX has higher annual earnings (EBITDA): 37.6M vs. MLEC (-5.24M). CTMX has more cash in the bank: 79.9M vs. MLEC (926K). CTMX has less debt than MLEC: CTMX (8.15M) vs MLEC (22.1M). CTMX has higher revenues than MLEC: CTMX (148M) vs MLEC (7.83M).
CTMXMLECCTMX / MLEC
Capitalization375M15.7M2,389%
EBITDA37.6M-5.24M-717%
Gain YTD131.068-50.875-258%
P/E Ratio4.97N/A-
Revenue148M7.83M1,889%
Total Cash79.9M926K8,629%
Total Debt8.15M22.1M37%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXMLEC
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 12 days ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBLX122.173.15
+2.65%
Roblox Corp
CXM9.010.23
+2.62%
Sprinklr
EQ0.420.01
+1.47%
Equillium
MRCC6.400.03
+0.47%
Monroe Capital Corp
BIOX3.75-0.06
-1.57%
Bioceres Crop Solutions Corp

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.42%
MLEC - CTMX
42%
Loosely correlated
-3.44%
BCAB - CTMX
37%
Loosely correlated
-3.74%
CRNX - CTMX
36%
Loosely correlated
+3.51%
VCYT - CTMX
36%
Loosely correlated
-3.77%
HOWL - CTMX
35%
Loosely correlated
+6.87%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with WINT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-3.44%
WINT - MLEC
49%
Loosely correlated
+16.67%
CTMX - MLEC
42%
Loosely correlated
-0.42%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
+5.91%
ABVC - MLEC
31%
Poorly correlated
+1.70%
More